CAR-T Therapy Pipeline Analysis Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

Sep 2021| TBR754C| TBRC (Publisher)

Report Highlights

Including: 1) By Target Antigen: CD19; CD22; BCMA; Others
2) By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others
Covering: Gilead Sciences; Novartis AG

CAR-T Therapy Pipeline Analysis Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T therapy market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Description:
Where is the largest and fastest growing market for the CAR-T therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CAR-T therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider CAR-T therapy market, and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application.
  • Market Characteristics – The market characteristics section of the report defines and explains the CAR-T therapy market. This chapter also defines and describes products covered in the report.
  • Customer Information – This chapter covers recent customers’ trends/preferences in the global CAR-T therapy market
  • Trends And Strategies – This chapter describes the major trends shaping the global CAR-T therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the CAR-T therapy market.
  • Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025),and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global CAR-T therapy market, estimated market shares and company profiles for the leading players.
  • Pipeline Analysis – This chapter covers information about the drugs currently in pipeline
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Opportunities And Strategies – This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for CAR-T therapy companies in terms of product offerings, geographic expansion, price offerings, and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • By Target Antigen: CD19; CD22; BCMA; Others
  • By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others

Companies Mentioned: Gilead Sciences; Novartis AG

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, CAR-T Therapy Pipeline Analysis Equipment indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 2 : Global CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 3 : Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 4 : Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 5 : Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 6 : Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 7 : Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 8 : Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 9 : Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10 : Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11 : Asia-Pacific CAR-T Therapy Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 12 : Asia-Pacific CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 13 : Asia-Pacific Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 14 : Asia Pacific Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 15 : Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 16 : Asia-Pacific CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 17 : Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 18 : Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 19 : China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 20 : China CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
  • Table 21 : China Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 22 : China Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 23 : China CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 24 : China CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 25 : China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 26 : China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio
  • Table 27 : India CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 28 : India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 29 : India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 30 : Japan CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 31 : Japan CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 32 : Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 33 : Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 34 : Australia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 35 : Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 36 : Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 37 : Indonesia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 38 : Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 39 : Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 40 : South Korea CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 41 : South Korea CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 42 : South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 43 : South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 44 : Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 45 : Western Europe CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 46 : Western Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 47 : Western Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 48 : Corporate Tax Structure In Western Europe Countries, %
  • Table 49 : Western Europe CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 50 : Western Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 51 : Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 52 : Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 53 : UK Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 54 : UK CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
  • Table 55 : UK Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 56 : UK Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 57 : UK CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 58 : UK CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 59 : UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 60 : UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 61 : Germany CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 62 : Germany CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 63 : Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 64 : Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 65 : France CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 66 : France CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 67 : France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 68 : France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 69 : Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 70 : Eastern Europe CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 71 : Eastern Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 72 : Eastern Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 73 : Eastern Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 74 : Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 75 : Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 76 : Russia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 77 : Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 78 : Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 79 : North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 80 : North America CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 81 : North America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 82 : North America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 83 : North America CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 84 : North America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 85 : North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 86 : North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 87 : USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 88 : USA CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
  • Table 89 : USA Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 90 : USA Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 91 : USA CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 92 : USA CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 93 : USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 94 : USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 95 : South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 96 : South America CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 97 : South America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 98 : South America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 99 : South America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 100 : South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 101 : South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 102 : Brazil CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 103 : Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 104 : Brazil CAR-T Therapy Market, Segmentation By Application , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 105 : Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 106 : Middle East CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 107 : Middle East Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 108 : Middle East Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 109 : Middle East CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 110 : Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 111 : Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 112 : Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 113 : Africa CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 114 : Africa Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 115 : Africa Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 116 : Africa CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 117 : Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 118 : Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 119 : Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 120 : Gilead Sciences – Financial Performance, 2016– 2020, $ Billion
  • Table 121 : Novartis AG – Financial Performance, 2016 – 2020, $ Billion
  • Table 122 : Pipeline Analysis Of CAR-T Cell Therapy
  • Table 123 : Global CAR-T Therapy Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 124 : Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Target Antigen, 2020 – 2025
  • Table 125 : Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
  • Table 126 : CAR-T Therapy Market - Data Sources
  • Figure 1 : Global CAR-T Therapy Market Segmentation By Target Antigen
  • Figure 2 : Global CAR-T Therapy Market Segmentation By Application
  • Figure 3 : Global CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 4 : Global CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 5 : Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 6 : Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 7 : Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 8 : Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 9 : Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 10 : Asia-Pacific CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 11 : Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 12 : China CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 13 : China CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 14 : China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15 : India CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 16 : India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17 : Japan CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 18 : Japan CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 19 : Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 20 : Australia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 21 : Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 22 : Indonesia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 23 : Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 24 : South Korea CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 25 : South Korea CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 26 : South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 27 : Western Europe CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 28 : Western Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 29 : Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 30 : UK CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 31 : UK CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 32 : UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 33 : Germany CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 34 : Germany CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 35 : Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 36 : France CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 37 : France CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 38 : France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 39 : Eastern Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 40 : Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 41 : Russia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 42 : Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 43 : North America CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 44 : North America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 45 : North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 46 : USA CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 47 : USA CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 48 : USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 49 : South America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 50 : South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51 : Brazil CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 52 : Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 53 : Middle East CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 54 : Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 55 : Africa CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 56 : Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 57 : Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 58 : Gilead Sciences – Financial Performance, 2016 – 2020, $ Billion
  • Figure 59 : Novartis AG – Financial Performance, 2016– 2020, $ Billion
  • Figure 60 : CAR-T Therapy Market, Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020
  • Figure 61 : CAR-T Therapy Market, Number Of Active Trials By Cancer Type
  • Figure 62 : CAR-T Therapy Market, Global CAR-T Cell Therapy By Trial Site
  • Figure 63 : CAR-T Therapy Market, Number of Molecules In Cancer Clinical Trials, By Target

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report